TAVR: Regression of Left Ventricular Hypertrophy Decreases Re-hospitalization

Original title: Early Regression of Severe Left Ventricular Hypertrophy After Transcatheter Aortic Valve Replacement Is Associated with Decreased Hospitalization. Reference: Brian Lindman, et al. JACC Cardiovasc Interv 2014;7:662-73.

 

Left ventricular hypertrophy, defined by the increase of left ventricular mass, has long been associated to increased morbi-mortality in the context of different heart conditions. LV hypertrophy regression might improve clinical outcomes.

This study analyzed 690 cohort A patients from the Partner trial (137 randomized and 553 from the registry). Patients presenting severe left ventricular hypertrophy were included (left ventricular mass index ≥149 g/m2 in men and ≥122 g/m2 in women).

Primary end point was a combination of all cause death, cardiac death, re hospitalization, stroke, renal failure, major bleeding, infarction and vascular complications. Mean population age was 85, aortic valve area, 0.65 cm2 and STS was 11.

At one year follow up, LV hypertrophy decreased from 166±31 g/m2 at baseline to 137±35 g/m2 (p<0.001), especially in women. No differences were observed from baseline ECG.

In more than half of the population regression was observed within 30 days after procedure. Those with lesser early regression were often obese and required definite pacemaker. After TAVI, those with greater regression had smaller VMI diameter and less wall thickness.

At 30 days and 12 month follow up there were no differences in all-cause mortality rates, but there was a lower re hospitalization rate for cardiac failure among those with greater early regression of VMI and this advantage was maintained throughout follow up period. 

Functional class and 6 minute walk test were similar, but those presenting early regression evolved with better quality of life and lower natriuretic peptide values.

 Conclusion

In patients with severe aortic stenosis and severe left ventricular hypertrophy receiving transcatheter aortic valve replacement, greater early regression of VM was associated with decreased re hospitalization compared to patients with lesser regression.

Commentary

Half LVMI cases happen within the first 30 days after procedure and last 12 months, which proves heart plasticity. This is associated to a lower re hospitalization rate and a better quality of life without affecting mortality.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Fundation
Buenos Aires – Argentina

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

 The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

Drug-Eluting Stents in Peripheral Arterial Disease: When Should They Be Used?

Peripheral drug-eluting stents have transformed the treatment of peripheral arterial disease by reducing restenosis rates and the need for repeat interventions. However, the emergence...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...